Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2809 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA warns on China-made infant formula

Although no Chinese manufacturers of infant formula have fulfilled the requirements to sell infant formula in the US, the FDA officials are investigating whether or not infant formula

FDA approves Talecris’s neurologic drug

The FDA designated Gamunex as an orphan drug to treat chronic inflammatory demyelinating polyneuropathy (CIDP). The FDA based its approval of Gamunex on clinical trials that showed Gamunex

Nucletron introduces new radiotherapy software

This innovation in treatment planning solutions from Nucletron allows clinicians to review radiotherapy plans that are generated with a wide variety of Dicom-compliant treatment planning systems, in a